Patent · US Active

Method for treating an inflammatory disease and/or an autoimmune disease with a soluble FcγRIIb

US10028998B2 · kind B2 · utility

2Cited by

3References

10Claims

0Family size

Assignee

SUPPREMOL GMBH · DE

Inventors

Peter Buckel · Bernried, DE
Peter Sondermann · Stockdorf, DE
Sascha Tillmanns · Munich, DE
Ingrid Berger · Munich, DE

Key dates

Filing date	Oct 30, 2012
Grant date	Jul 24, 2018
Priority date	—
Expiry date	Oct 30, 2032

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K14/70535
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to a method for treating or preventing either one or both of an inflammatory disease and an autoimmune disease in a patient, wherein the method comprises providing a pharmaceutical composition containing a therapeutically effective amount of soluble FcγR; administering said composition to a patient, followed by a safety period of several weeks, followed by a subsequent treatment cycle of at least two weekly administrations, wherein said therapeutically effective amount is effective to treat or prevent said disease in said patient. The present invention also provides a pharmaceutical composition in the form of a multiple-dosage-kit which contains sufficient amounts of administration doses of soluble FcγR for effectively treating or preventing inflammatory diseases and/or autoimmune diseases in a patient.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.